The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the ...

A great-grandmother from Doncaster visited St Thomas’ Hospital to give thanks and celebrate 50 years since her life-saving ...

A Caithness woman who received "life-changing" surgery at a Clydebank hospital has thanked staff there for giving her a ...

FOR patients battling heart conditions, the evolution of treatments continues to offer hope, especially with the advent of ...

"I want to wear what he wears," dad Eric Conklin tells PEOPLE of his son Bennett, who was born with a congenital heart defect ...

While effective, open-heart surgery involves longer hospital stays, more recovery time, and carries higher risks of complications like infection, bleeding, or stroke - particularly in older or ...

Partial heart transplants for congenital heart disease using donor semilunar valves showed valve growth matching patient development in infants. Transplanted valves functioned well over time, with no ...

Ebstein anomaly is a defect of the tricuspid valve in the heart. It is a rare type of heart defect, occurring in about 1 out of 10,000 live births each year. The age of onset for symptoms of Ebstein ...

Researchers at the University of California, Irvine have successfully performed preclinical laboratory testing of a replacement heart valve intended for toddlers and young children with congenital ...

Congenital heart defects affect approximately 1% of births in the United States and Europe, with >1 million children in the United States living with congenital heart defects. Many experience ...

Lung volume reduction surgery (LVRS) is a treatment for end-stage lung disease caused by emphysema. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that causes shortness of breath ...

Sarasota Memorial Hospital is one of the first hospitals to use a new FDA-approved treatment for failing tricuspid valves. The new procedure is less invasive than traditional surgery and allows ...